LION
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
P/B -2.78 suggests liabilities exceed assets; Forward P/E is excessive given the earnings trend.
- Negative Price/Book ratio
- High Forward P/E of 54.55
Revenue growth is insufficient to offset the collapse in earnings per share.
- Q/Q Revenue growth of 15.3%
- YoY EPS growth of -96%
Price performance is bullish, but earnings performance is consistently bearish.
- Strong 1Y and 6M price appreciation
- Poor earnings surprise track record (-42.75% avg)
A Piotroski score of 0 indicates the worst possible financial health profile.
- Piotroski F-Score 0/9
- Negative Equity
Dividend strength is 0/100.
- No dividend payments
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for LION and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
LION
Lionsgate Studios Corp.
Primary
|
+26.0% | +19.9% | +75.6% | +91.8% | +30.0% | +6.1% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Ownership Structure
Institutional and insider holdings breakdown
Ownership Breakdown
Top Institutional Holders
Key Insiders
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-01 | RACHESKY MARK H. | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award | 7,983 | $75,998 |
| 2026-04-01 | ROSENBLATT RICHARD M | Director | Stock Award | 5,252 | $49,999 |
| 2026-04-01 | HARKEY JOHN DANIEL JR | Director | Stock Award | 6,828 | $65,003 |
| 2026-04-01 | SLOAN HARRY EVANS | Director | Stock Award | 6,828 | $65,003 |
| 2026-04-01 | CRAWFORD GORDON | Director | Stock Award | 6,303 | $60,005 |
| 2026-04-01 | FINE EMILY | Director | Stock Award | 5,252 | $49,999 |
| 2026-04-01 | OSTOLAZA YVETTE | Director | Stock Award | 6,303 | $60,005 |
| 2025-12-23 | BURNS MICHAEL RAYMOND | Officer | Sale | 21,748 | $195,949 |
| 2025-12-22 | FELTHEIMER JON HENRY | Chief Executive Officer | Sale | 195,000 | $1,614,600 |
| 2025-12-18 | GOLDSMITH BRIAN | Chief Operating Officer | Sale | 25,000 | $213,500 |
| 2025-11-28 | RACHESKY MARK H. | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award | 30,295 | $226,001 |
| 2025-11-28 | ROSENBLATT RICHARD M | Director | Stock Award | 25,528 | $40,441 |
| 2025-11-28 | HARKEY JOHN DANIEL JR | Director | Stock Award | 28,820 | $64,999 |
| 2025-11-28 | SLOAN HARRY EVANS | Director | Stock Award | 28,830 | $65,074 |
| 2025-11-28 | CRAWFORD GORDON | Director | Stock Award | 28,150 | $60,001 |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning LION from our newsroom.